{"id":"https://openalex.org/W1998013296","doi":"https://doi.org/10.1002/cmdc.201300012","title":"Editorial: The Role of Medicinal Chemistry in Treating Obesity, Diabetes and Metabolic Syndrome","display_name":"Editorial: The Role of Medicinal Chemistry in Treating Obesity, Diabetes and Metabolic Syndrome","publication_year":2013,"publication_date":"2013-03-25","ids":{"openalex":"https://openalex.org/W1998013296","doi":"https://doi.org/10.1002/cmdc.201300012","mag":"1998013296","pmid":"https://pubmed.ncbi.nlm.nih.gov/23529925"},"language":"en","primary_location":{"id":"doi:10.1002/cmdc.201300012","doi":"https://doi.org/10.1002/cmdc.201300012","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cmdc.201300012","pdf_url":null,"source":{"id":"https://openalex.org/S136164820","display_name":"ChemMedChem","issn_l":"1860-7179","issn":["1860-7179","1860-7187"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030185028","display_name":"Natalia Ort\u00fazar","orcid":"https://orcid.org/0000-0002-9920-6150","observed_orcids":["https://orcid.org/0000-0002-9920-6150"]},"institutions":[{"id":"https://openalex.org/I4210085863","display_name":"John Wiley & Sons (Germany)","ror":"https://ror.org/000gm1k91","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210085863","https://openalex.org/I4210131007"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Natalia Ort\u00fazar","raw_affiliation_strings":["ChemMedChem, Co-owned and supported by ChemPubSoc Europe, Wiley-VCH, Boschstrasse 12, 69469 Weinheim (Germany), Homepage: www.chemmedchem.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ChemMedChem, Co-owned and supported by ChemPubSoc Europe, Wiley-VCH, Boschstrasse 12, 69469 Weinheim (Germany), Homepage: www.chemmedchem.org","institution_ids":["https://openalex.org/I4210085863"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030185028"],"corresponding_institution_ids":["https://openalex.org/I4210085863"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"4","first_page":"535","last_page":"537"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.9470000267028809},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9990000128746033},{"id":"https://openalex.org/keywords/obesity-pharmacotherapy","display_name":"obesity pharmacotherapy","score":0.671999990940094},{"id":"https://openalex.org/keywords/anti-obesity-drugs","display_name":"anti-obesity drugs","score":0.800000011920929},{"id":"https://openalex.org/keywords/orlistat","display_name":"orlistat","score":0.8769999742507935},{"id":"https://openalex.org/keywords/lorcaserin","display_name":"lorcaserin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/phentermine","display_name":"phentermine","score":0.8640000224113464},{"id":"https://openalex.org/keywords/topiramate","display_name":"topiramate","score":0.9520000219345093},{"id":"https://openalex.org/keywords/rimonabant","display_name":"rimonabant","score":0.902999997138977},{"id":"https://openalex.org/keywords/cb1-receptor-agonists","display_name":"CB1 receptor agonists","score":0.8539999723434448},{"id":"https://openalex.org/keywords/appetite-suppression","display_name":"appetite suppression","score":0.6639999747276306},{"id":"https://openalex.org/keywords/angiopoietin-like-proteins","display_name":"angiopoietin-like proteins","score":0.8410000205039978},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.9890000224113464},{"id":"https://openalex.org/keywords/lipid-metabolism","display_name":"lipid metabolism","score":0.5199999809265137},{"id":"https://openalex.org/keywords/rmi1","display_name":"RMI1","score":0.7490000128746033},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C511355011","wikidata":"https://www.wikidata.org/wiki/Q12174","display_name":"Obesity","level":2,"score":0.7615525126457214},{"id":"https://openalex.org/C2780780548","wikidata":"https://www.wikidata.org/wiki/Q424163","display_name":"Orlistat","level":4,"score":0.7012417316436768},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6827677488327026},{"id":"https://openalex.org/C2778456266","wikidata":"https://www.wikidata.org/wiki/Q418157","display_name":"Phentermine","level":4,"score":0.6252285242080688},{"id":"https://openalex.org/C544821477","wikidata":"https://www.wikidata.org/wiki/Q718113","display_name":"Weight loss","level":3,"score":0.5450929999351501},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5240705013275146},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.515447199344635},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.5128569602966309},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5093425512313843},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.48362651467323303},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.43427687883377075},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3910577595233917},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.35144150257110596},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.31435346603393555},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.2872263193130493},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27703288197517395},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14680203795433044},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.14656445384025574},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069450","descriptor_name":"Liraglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/cmdc.201300012","doi":"https://doi.org/10.1002/cmdc.201300012","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cmdc.201300012","pdf_url":null,"source":{"id":"https://openalex.org/S136164820","display_name":"ChemMedChem","issn_l":"1860-7179","issn":["1860-7179","1860-7187"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"journal-article"},{"id":"pmid:23529925","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23529925","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"Editorial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2169317915","https://openalex.org/W2084619349","https://openalex.org/W3112975101","https://openalex.org/W4205427408","https://openalex.org/W3046217939","https://openalex.org/W2181935015","https://openalex.org/W4393865791","https://openalex.org/W2115115480","https://openalex.org/W4312325758","https://openalex.org/W3126161489"],"abstract_inverted_index":{"In":[0,530,722,1170],"today\u2032s":[1],"world,":[2],"obesity,":[3,378],"diabetes":[4,43,414,425,473,493,783,802,1048],"and":[5,13,27,34,94,108,133,152,191,245,259,351,357,373,406,459,468,486,523,631,633,637,662,671,680,712,745,750,766,810,841,879,883,886,926,941,960,977,1012,1052,1072,1159],"metabolic":[6,355,1059,1088],"syndrome":[7,998],"are":[8,24,124,343,395,521,545,624,732,830,1049,1096,1175],"major":[9,58],"global":[10],"health":[11,19,60],"issues,":[12],"collectively,":[14],"their":[15,701],"impact":[16],"on":[17,103,328,645],"human":[18],"is":[20,118,143,183,197,205,314,433,535,553,583,595,714,999,1076,1078,1106],"severe.":[21],"These":[22],"disorders":[23],"highly":[25,1107],"related":[26,854,1139],"interlinked":[28],"through":[29,160,251,1160],"various":[30],"factors,":[31],"both":[32,682],"environmental":[33,171],"physiological.":[35],"Arguably,":[36],"the":[37,49,66,78,86,104,137,163,174,199,207,228,239,293,302,312,339,366,375,387,420,439,460,495,512,556,563,609,646,654,666,685,708,778,792,797,824,843,861,899,910,914,1020,1039,1043,1056,1084,1091,1176],"current":[38,318],"prevalence":[39,79,376],"of":[40,52,68,80,88,106,131,141,154,162,177,201,213,295,341,353,368,377,401,413,422,490,497,611,648,656,668,684,688,710,780,791,799,826,863,901,906,995,1002,1023,1038,1045,1058,1083,1087,1121,1164,1185],"type":[41,89,370,491,531,735,781,800],"2":[42,90,371,532,736,782,801],"can":[44,157,263,474],"be":[45,147,264,616,814,1114,1130],"largely":[46],"attributed":[47],"to":[48,127,146,184,242,256,305,386,442,451,454,479,506,526,547,589,597,615,652,707,724,734,813,833,846,955,1098,1116,1132,1141,1152,1178],"increased":[50,465,1008],"incidence":[51],"obesity.":[53,135,788],"Obesity":[54,98,363],"has":[55,99,613,694,893],"become":[56,1101],"a":[57,100,233,285,315,434,560,585,755,768,819,873,1000,1025,1110,1153],"public":[59],"concern":[61],"in":[62,72,115,192,238,271,311,338,404,764,787,967,1119],"recent":[63,269],"years,":[64],"with":[65,274,398,424,562,700,784,816,838,850,876,1136,1167],"number":[67,421],"obese":[69,181],"individuals":[70,182,423],"increasing":[71,918,937],"almost":[73],"all":[74],"areas":[75],"worldwide.":[76],"As":[77],"obesity":[81,142,296,342,1046],"increases,":[82],"so":[83],"too":[84],"do":[85],"comorbidities":[87],"diabetes,":[91,372,533,827,1031],"cardiovascular":[92,704],"disease,":[93,483,485],"other":[95,942],"associated":[96,461,699,837,1166],"diseases.":[97],"dramatic":[101],"effect":[102],"quality":[105],"life":[107,111],"decreases":[109],"typical":[110],"expectancy.":[112],"With":[113],"this":[114],"mind,":[116],"it":[117,156,379,1105,1124],"unsurprising":[119],"that":[120,236,279,288,555,568,587,639,664,747,980,1016,1079,1109,1127],"significant":[121],"research":[122,319,892],"efforts":[123],"currently":[125,214,396,715,794,949],"underway":[126],"find":[128],"new":[129,864,953],"means":[130],"preventing":[132],"controlling":[134],"While":[136,1104],"most":[138],"common":[139],"cause":[140,475],"generally":[144],"considered":[145],"disparity":[148],"between":[149],"daily":[150],"intake":[151],"expenditure":[153,991],"energy,":[155],"also":[158,198,280,344,894,1050],"arise":[159],"malfunction":[161],"endocrine":[164],"system":[165,1086],"caused":[166,308,437],"by":[167,224,309,418,438,504],"genetic":[168],"defects":[169],"or":[170,447,499,520,574,855,936,993,1034,1150],"factors.":[172],"Typically,":[173],"first":[175,580],"approach":[176],"clinicians":[178],"when":[179],"treating":[180,961],"recommend":[185],"lifestyle":[186],"changes":[187],"(diet,":[188],"exercise,":[189],"etc.),":[190],"extreme":[193],"cases,":[194],"surgery.":[195],"There":[196],"option":[200],"pharmaceutical":[202,1187],"intervention,":[203],"which":[204,220,247,1094],"where":[206],"medicinal":[208,557],"chemist":[209,558],"steps":[210],"in.":[211],"Examples":[212],"available":[215,733,822,845],"therapeutics":[216,829],"include":[217],"orlistat":[218],"(tetrahydrolipstatin),":[219],"promotes":[221,248],"weight":[222,249,282,1149],"loss":[223,250],"inhibiting":[225,931],"gastrointestinal":[226],"lipase,":[227],"recently":[229,762],"approved":[230,291,763,795],"lorcaserin":[231],"(APD-356),":[232],"serotonergic":[234],"agent":[235],"acts":[237,588],"brain":[240],"leading":[241,255,453],"appetite":[243,260],"suppression,":[244],"phentermine,":[246],"adrenal":[252],"gland":[253],"stimulation":[254],"norepinephrine":[257],"release":[258],"suppression\u2014interestingly,":[261],"phentermine":[262],"administered":[265,546,774],"alone":[266],"or,":[267],"since":[268,429],"approval,":[270],"combination":[272],"(Qsymia\u2122)":[273],"topiramate,":[275],"an":[276,600],"anticonvulsant":[277],"drug":[278,582,728,1112],"causes":[281],"loss.":[283],"Rimonabant,":[284],"CB1":[286,322],"agonist":[287,773,875],"was":[289,298],"briefly":[290],"for":[292,718,777,796,823,898,963,984,1042,1055,1061,1181],"treatment":[294,340,565,779,798,808,1044,1057],"but":[297,538,1138],"subsequently":[299],"withdrawn":[300],"from":[301],"market":[303],"due":[304,478],"side":[306,697,835],"effects":[307,698,705,836,881,889],"action":[310,612],"brain,":[313],"cautionary":[316],"tale;":[317],"looking":[320],"at":[321,1093],"agonists":[323,676],"as":[324,347,381,416,464,511,599,678,853,871,917,972,1030,1067,1080],"anorectic":[325],"agents":[326,333,544,567,623,731,793,865,1174],"focuses":[327],"peripherally":[329],"expressed":[330],"receptors.":[331],"New":[332],"acting":[334,866],"against":[335,867],"novel":[336,896,908,947],"targets":[337,897,948,965,1040,1135],"emerging,":[345],"such":[346,463,677,852,870,916,971,1029,1066],"angiopoietin-like":[348],"proteins,":[349],"adipokines,":[350],"modulators":[352],"lipid":[354,887],"enzymes":[356],"recQ-mediated":[358],"genome":[359],"instability":[360],"1":[361,492,1189,1190],"(RMI1).":[362],"significantly":[364,1018],"increases":[365],"risk":[367,1022,1163],"developing":[369,1024],"given":[374],"comes":[380],"little":[382],"surprise":[383],"that,":[384],"according":[385],"World":[388],"Health":[389],"Organization,":[390],"347":[391],"million":[392],"people":[393],"worldwide":[394],"diabetic,":[397],"80":[399],"%":[400],"those":[402,849,979],"living":[403],"middle":[405],"low":[407],"income":[408],"countries.":[409],"If":[410],"incident":[411],"rates":[412],"continue":[415,859],"expected,":[417],"2030":[419],"will":[426,1113,1129],"have":[427,516],"doubled":[428],"2005.":[430],"Diabetes":[431],"mellitus":[432],"chronic":[435,839],"disease":[436,804,1033],"body\u2032s":[440],"inability":[441],"either":[443,517,569],"produce":[444],"(type":[445,449],"1)":[446],"respond":[448],"2)":[450],"insulin,":[452,657],"high":[455,1005],"blood":[456,508,549,751,957,1006,1009,1145],"glucose":[457,509,550,592,752,958,985,1010,1146],"levels":[458,510,959,1011],"symptoms":[462],"hunger,":[466],"thirst":[467],"frequent":[469],"urination.":[470],"Left":[471],"untreated,":[472],"neuropathy,":[476],"blindness":[477],"retina":[480],"damage,":[481],"kidney":[482],"heart":[484,1032],"stroke.":[487,1035],"The":[488,579],"management":[489,825],"involves":[494],"administration":[496],"insulin":[498,501,534,919,938],"synthetic":[500],"analogues,":[502],"usually":[503],"injection,":[505],"control":[507,548,1089],"pancreatic":[513,571,649],"\u03b2":[514,650],"cells":[515,651],"been":[518],"destroyed":[519],"dysfunctional":[522],"thus":[524],"unable":[525],"generate":[527],"endogenous":[528],"insulin.":[529,578,817],"sometimes":[536],"used":[537],"more":[539,726,1026,1102,1154],"often":[540],"than":[541],"not,":[542],"oral":[543,807],"levels.":[551],"It":[552],"here":[554],"plays":[559],"role,":[561],"standard":[564],"involving":[566],"increase":[570,653,1019],"secretion":[572,655],"of,":[573],"cellular":[575],"sensitivity":[576,920],"to,":[577],"line":[581],"metformin,":[584],"biguanide":[586],"suppress":[590],"hepatic":[591],"production.":[593],"Metformin":[594],"hypothesized":[596],"act":[598,640],"adenosine":[601],"monophophate":[602],"(AMP)-activated":[603],"protein":[604,927],"kinase":[605,923,934],"(AMPK)":[606],"agonist,":[607],"although":[608],"mechanism":[610],"yet":[614],"fully":[617],"elucidated.":[618],"When":[619],"metformin":[620],"fails,":[621],"additional":[622],"prescribed,":[625],"including":[626,738,1004],"sulfonylureas":[627],"(e.g.,":[628,635,660],"glipizide,":[629],"glimepiride":[630],"glyburide)":[632],"meglitinides":[634],"repaglinide":[636],"nateglinide)":[638],"via":[641,775],"ATP-dependent":[642],"K+":[643],"channels":[644],"membrane":[647],"\u03b1-glucosidase":[658],"inhibitors":[659,742],"acarbose":[661],"miglitol)":[663],"prevent":[665,803],"metabolism":[667],"dietary":[669],"carbohydrates,":[670],"peroxisome":[672],"proliferator-activated":[673],"receptor":[674,772,1070],"(PPAR)":[675],"rosiglitazone":[679],"pioglitazone,":[681],"members":[683],"thiazolidinedione":[686],"class":[687,693],"antidiabetic":[689,902],"agents.":[690,903],"This":[691],"latter":[692],"had":[695],"serious":[696,1027],"use;":[702],"adverse":[703],"led":[706],"withdrawal":[709],"rosiglitazone,":[711],"pioglitazone":[713],"being":[716],"investigated":[717],"potential":[719],"cancer-promoting":[720],"effects.":[721],"addition":[723],"these":[725,907,1122,1168],"established":[727],"classes,":[729],"newer":[730],"diabetics":[737],"dipeptidyl":[739],"peptidase-4":[740],"(DPP4)":[741],"saxagliptin,":[743],"sitagliptin":[744],"linagliptin":[746],"decrease":[748],"glucagon":[749],"levels,":[753,1015,1147],"dapagliflozin,":[754],"first-in-class":[756],"sodium-glucose":[757],"linked":[758],"transporter":[759],"(SGLT)-2":[760],"inhibitor":[761],"Europe,":[765],"liraglutide,":[767],"glucagon-like":[769],"peptide-1":[770],"(GLP-1)":[771],"injection":[776],"off-label":[785],"use":[786,840],"Unfortunately,":[789],"none":[790],"progression.":[805],"Ultimately,":[806],"fails":[809],"patients":[811,1143],"need":[812],"treated":[815],"Despite":[818],"strong":[820],"arsenal":[821],"improved":[828,1172,1179],"continually":[831],"needed":[832],"eliminate":[834],"improve":[842],"options":[844],"patients,":[847],"particularly":[848],"complications":[851,1165],"unrelated":[856],"conditions.":[857],"Investigations":[858],"into":[860],"identification":[862],"known":[868],"targets,":[869,909],"aleglitazar,":[872],"PPAR\u03b1/\u03b3":[874],"fuel":[877,884],"storage":[878],"insulin-sensitizing":[880],"(\u03b3)":[882],"burning":[885],"modulating":[888,956,989],"(\u03b1).":[890],"Recent":[891],"uncovered":[895],"development":[900],"For":[904],"some":[905],"therapeutic":[911,1173],"rationale":[912],"remains":[913],"same,":[915],"(glycogen":[921],"synthase":[922],"3":[924],"(GSK3)":[925],"tyrosine":[928],"phosphatase-1B":[929],"(PTP-1B)),":[930],"gluconeogenesis":[932],"(dehydrogenase":[933],"(PDH)),":[935],"production/secretion":[939],"(GLP-1":[940],"gut":[943],"hormone":[944],"receptors).":[945],"Other":[946],"under":[950,1053],"investigation":[951,1054],"involve":[952],"approaches":[954],"diabetes:":[962],"example,":[964,1062],"involved":[966],"fatty":[968],"acid":[969,1064],"metabolism,":[970],"carnitine":[973],"palmitoyltransferase":[974],"(CPT)":[975],"I":[976],"II,":[978],"offer":[981],"alternative":[982],"routes":[983],"excretion,":[986],"like":[987],"SGLT,":[988],"energy":[990],"(\u03b2(3)-adrenoceptor),":[992],"inhibition":[994],"lipolysis.":[996],"Metabolic":[997],"collection":[1001],"conditions,":[1003],"pressure,":[1007],"abnormal":[1013],"cholesterol":[1014],"together":[1017],"individual\u2032s":[1021],"condition,":[1028],"Unsurprisingly,":[1036],"many":[1037],"described":[1041],"and/or":[1047],"indicated":[1051],"syndrome,":[1060],"bile":[1063],"receptors,":[1065],"farnesoid":[1068],"X":[1069],"(FXR)":[1071],"GPBAR1":[1073],"(TGR5).":[1074],"What":[1075],"clear":[1077],"our":[1081],"understanding":[1082],"intricate":[1085],"deepens,":[1090],"points":[1092],"we":[1095,1128],"able":[1097,1115,1131],"intervene":[1099],"therapeutically":[1100],"numerous.":[1103],"unlikely":[1108],"single":[1111],"prove":[1117],"curative":[1118],"any":[1120,1186],"diseases,":[1123],"seems":[1125],"probable":[1126],"modulate":[1133],"several":[1134],"distinct":[1137],"pharmacology":[1140],"give":[1142],"controlled":[1144],"stabilized":[1148],"access":[1151],"healthy":[1155],"body":[1156],"mass":[1157],"index,":[1158],"this,":[1161],"decreased":[1162],"disorders.":[1169],"short,":[1171],"key":[1177],"prognosis":[1180],"patients\u2014the":[1182],"end":[1183],"goal":[1184],"endeavor.":[1188],"Dr.":[1191],"Natalia":[1192],"Ort\u00fazar":[1193],"Editor-in-Chief":[1194],"ChemMedChem":[1195]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}